Following the suspension of Olivier Giroud, German striker Lukas Podolski is expected to fill in the gap by starting as a centre-forward against QPR this afternoon.
The former Bayern Munich striker – who has 71 appearances for the senior German side – was first given the role of a number nine in his debut match for Arsenal FC against Sunderland back in August 2012.
Podolski also played as a central striker in last Sunday’s 1-1 draw with Manchester United at the Emirates.
But despite his willingness to keep that position on the field, manager Arsene Wenger believes his chances of maintaining that role will depend on how well he performs up front whenever the opportunity arises.
Wenger told reporters: “Of course, it is a good opportunity [against QPR] for him to show that he has a future in this position and that he can finish.
“But first I must decide to play him there. I believe it is his best position maybe because on the flanks he needs to work so hard and he is more a finisher than anyone else in the team.”
The Arsenal boss also pointed out that there was a lot competition for the central attacking position, due to the higher chances of scoring more goals.
“He [Podolski] wants to play there; but today, all the players who play on the flanks want to play there."
The Gunners face Queens Park Rangers at the Loftus Road tonight in a key game in the race for Champions League qualification.
With a game more than their city rivals Tottenham, Arsenal currently sit in fourth place in the Premier League standings, whereas QPR found themselves a spot above the bottom of the table.
Write for GiveMeSport! Sign-up to the GMS Writing Academy here:http://bit.ly/12nAsNY
DISCLAIMER: This article has been written by a member of the GiveMeFootball Writing Academy and does not represent the views of GiveMeFootball.com or SportsNewMedia. The views and opinions expressed are solely that of the author credited at the top of this article. GiveMeFootball.com and SportsNewMedia do not take any responsibility for the content of its contributors.